138 related articles for article (PubMed ID: 34622447)
1. Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.
Rodríguez-Lobato LG; Pereira A; Fernández de Larrea C; Cibeira MT; Tovar N; Jiménez-Segura R; Moreno DF; Oliver-Caldés A; Rosiñol L; Bladé J
Br J Haematol; 2022 Feb; 196(3):649-659. PubMed ID: 34622447
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982-2017.
Langseth ØO; Myklebust TÅ; Johannesen TB; Hjertner Ø; Waage A
Br J Haematol; 2020 Nov; 191(3):418-425. PubMed ID: 32367512
[TBL] [Abstract][Full Text] [Related]
3. Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
Pozzi S; Marcheselli L; Bari A; Liardo EV; Marcheselli R; Luminari S; Quaresima M; Cirilli C; Ferri P; Federico M; Sacchi S
Br J Haematol; 2013 Oct; 163(1):40-6. PubMed ID: 23889344
[TBL] [Abstract][Full Text] [Related]
4. Trends in survival of multiple myeloma: a thirty-year population-based study in a single institution.
Ríos-Tamayo R; Sánchez MJ; Puerta JM; Sáinz J; Chang DY; Rodríguez T; López P; de Pablos JM; Navarro P; de Veas JL; Romero A; Garrido P; Moratalla L; Alarcón-Payer C; López-Fernández E; González PA; Jiménez-Moleón JJ; Calleja-Hernández MÁ; Jurado M
Cancer Epidemiol; 2015 Oct; 39(5):693-9. PubMed ID: 26277330
[TBL] [Abstract][Full Text] [Related]
5. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.
Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Björkholm M
J Clin Oncol; 2007 May; 25(15):1993-9. PubMed ID: 17420512
[TBL] [Abstract][Full Text] [Related]
6. Real-world epidemiology, treatment patterns and survival of multiple myeloma patients in a large nationwide health plan.
Weil C; Gelerstein S; Sharman Moser S; Chodick G; Barit Ben-David N; Shalev V; Shofaniyeh I; Kamalov R; Meytes D
Leuk Res; 2019 Oct; 85():106219. PubMed ID: 31473468
[TBL] [Abstract][Full Text] [Related]
7. The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.
Munker R; Shi R; Nair B; Devarakonda S; Cotelingam JD; McLarty J; Mills GM; Glass J
Acta Haematol; 2016; 135(3):146-55. PubMed ID: 26588024
[TBL] [Abstract][Full Text] [Related]
8. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
Blimark CH; Turesson I; Genell A; Ahlberg L; Björkstrand B; Carlson K; Forsberg K; Juliusson G; Linder O; Mellqvist UH; Nahi H; Kristinsson SY;
Haematologica; 2018 Mar; 103(3):506-513. PubMed ID: 29217784
[TBL] [Abstract][Full Text] [Related]
9. Revised International Staging System Applied to Real World Multiple Myeloma Patients.
Jimenez-Zepeda VH; Duggan P; Neri P; Rashid-Kolvear F; Tay J; Bahlis NJ
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):511-518. PubMed ID: 27425179
[TBL] [Abstract][Full Text] [Related]
10. Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Fabre C; Koscielny S; Mohty M; Fegueux N; Blaise D; Maillard N; Tabrizi R; Michallet M; Socié G; Yakoub-Agha I; Garban F; Uzunov M; François S; Contentin N; Lapusan S; Bourhis JH
Haematologica; 2012 Apr; 97(4):482-90. PubMed ID: 22058218
[TBL] [Abstract][Full Text] [Related]
11. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013.
Andres M; Feller A; Arndt V;
Cancer Epidemiol; 2018 Apr; 53():105-110. PubMed ID: 29414629
[TBL] [Abstract][Full Text] [Related]
12. Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics.
Willenbacher E; Weger R; Rochau U; Siebert U; Willenbacher W;
PLoS One; 2016; 11(3):e0147381. PubMed ID: 26937956
[TBL] [Abstract][Full Text] [Related]
13. Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.
Pulte D; Gondos A; Brenner H
Oncologist; 2011; 16(11):1600-3. PubMed ID: 21968047
[TBL] [Abstract][Full Text] [Related]
14. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
[No Abstract] [Full Text] [Related]
15. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
Soutar RL; Dawson AA; Wilson BJ
Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
Kazmi SM; Nusrat M; Gunaydin H; Cornelison AM; Shah N; Kebriaei P; Nieto Y; Parmar S; Popat UR; Oran B; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH; Bashir Q
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):687-93. PubMed ID: 26361647
[TBL] [Abstract][Full Text] [Related]
17. Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.
Afram G; Susek KH; Uttervall K; Wersäll JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H
Eur J Haematol; 2021 Apr; 106(4):546-554. PubMed ID: 33471414
[TBL] [Abstract][Full Text] [Related]
18. Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.
Pulte D; Redaniel MT; Brenner H; Jansen L; Jeffreys M
Leuk Lymphoma; 2014 May; 55(5):1083-9. PubMed ID: 23879201
[TBL] [Abstract][Full Text] [Related]
19. Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study.
Turesson I; Velez R; Kristinsson SY; Landgren O
J Clin Oncol; 2010 Feb; 28(5):830-4. PubMed ID: 20038719
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and survival trends in Finnish multiple myeloma patients-a nationwide real-world evidence study.
Toppila I; Miettinen T; Lassenius MI; Lievonen J; Bauer M; Anttila P
Ann Hematol; 2021 Jul; 100(7):1779-1787. PubMed ID: 33712865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
